Serum inflammatory markers in overweight children and adolescents with non-alcoholic fatty liver disease

Israel Medical Association Journal

Volumn 12, Issue 7, 2010, Pages 410-415

  Neuman, Gal ^a   Sagi, Rami ^b   Shalitin, Shlomit ^b   Reif, Shimon ^b  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Infammatory markers; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Obesity; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; SERUM AMYLOID A; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CELL COUNT; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEPATORENAL INDEX; HUMAN; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; COMPLICATION; FATTY LIVER; INFLAMMATION; YOUNG ADULT;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; ERYTHROCYTE AGGREGATION; FATTY LIVER; FEMALE; HUMANS; INFLAMMATION; MALE; OBESITY; PROSPECTIVE STUDIES; SERUM AMYLOID A PROTEIN; YOUNG ADULT; BIOMARKERS;

EID: 77955074181     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
2. Roberts EA. Nonalcoholic steatohepatitis in children. Clin Liver Dis 2007; 11(1): 155-72.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
4. Cortez-Pinto H, Camilo ME, Baptista A, et al. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999; 18: 353-8.
5. Koruk M, Savas MC, Yilmaz O, et al. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis. Turk J Gastroenterol 2003; 14: 12-17.
6. Osawa H, Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 1996; 24: 25-9.
7. Nobili V, Manco M. Terapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers. World J Gastroenterol 2007; 13(18): 2639-41.
8. Krebs NF, Jacobson MS, American Academy of Pediatrics Committee on Nutrition. Prevention of pediatric overweight and obesity. Pediatrics 2003; 112: 424-30.
9. Mei Z, Scanlon KS, Grummer-Strawn LM, et al. Increasing prevalence of overweight among US low-income preschool children: Te Centers for Disease Control and Prevention Pediatric Nutrition Surveillance, 1983 to 1995. Pediatrics 1998; 101: 103-5.
10. Gavish D. Childhood obesity/overweight: early diagnosis to prevent premature cardiovascular disease [Editorial]. IMAJ Isr Med Assoc J 2007; 9: 813.
11. Meyerovitch J, Goldman R, Avner-Cohen H, Antebi F, Sherf M. Primary care screening for childhood obesity: a population-based analysis. IMAJ Isr Med Assoc J 2007; 9: 782-6.
12. Henkin Y. Cardiovascular risk factors in young adults - are we neglecting the next generation? [Editorial]. IMAJ Isr Med Assoc J 2006; 8: 570-2.
13. Ogden CL, Troiano R P, Briefel RR, et al. Prevalence of overweight among preschool children in the United States, 1971 through 1994. Pediatrics 1997; 99: E1.
14. Lavine JE, Schwimmer JB. Non-alcoholic fatty liver disease in the pediatric population. Clin Liver Dis 2004; 8: 549-58.
15. Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997; 42: 1428-32.
16. Tominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relation to obesity: an epidemiological ultrasonographic survey. Dig Dis Sci 1995, 40: 2002-9.
17. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-93.
18. Visser M, Bouter LM, Mcquillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-5.
19. Festa A, D'Agostino R Jr, Williams K, et al. Te relation of body fat mass and distribution to markers of chronic infammation. Int J Obes Relat Metab Disord 2001; 25: 1407-15.
20. Visser M, Bouter LM, McQuillan GM, et al. Low grade systemic inflammation in overweight children. Pediatrics 2001; 107: E13.
21. Libby P, Ridker PM, Maseri A. Infammation and atherosclerosis. Circulation 2002; 105: 1135-43.
22. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365-72.
23. Ridker PM, Cannon C P, Morrow D, et al. Pravastatin or Atorvastatin Evaluation and Infection Terapy - Trombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes afer statin therapy. N Engl J Med 2005; 352: 20-8.
24. Samocha-Bonet D, Lichtenberg D, Tomer A, et al. Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade infammation. Obes Res 2003; 11: 403-7.
25. Fusman G, Mardi T, Justo D, et al. Red blood cell adhesiveness/aggregation, C-reactive protein, fbrinogen, and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. Am J Cardiol 2002; 90: 561-3.